Learn More
Medchemexpress LLC LY3522348 | 2568608-48-8 | 98.3% | 409.41 | 500 MG

Supplier: Medchemexpress LLC HY149987500MG
LY3522348 (KHK-IN-3) is a ketohexokinase (KHK) inhibitor. KHK is a rate-limiting enzyme and fructokinase involved in fructose metabolism, catalyzing the phosphorylation of fructose to fructose-1-phosphate (FIP) at the expense of ATP. The lack of feedback inhibition in fructose metabolism leads to the accumulation of downstream intermediates such as lipogenesis, gluconeogenesis, and oxidative phosphorylation.
- Ketohexokinase (KHK) inhibitor
- Can be used in the study of kidney disease
- Can be used in the study of nonalcoholic steatohepatitis (NASH)
- Can be used in the study of diabetes
- Can be used in the study of heart failure
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.